Clopidogrel for the hot patient.
作者信息
Bilodeau Matthew L, Simon Daniel I
出版信息
Circ Cardiovasc Interv. 2009 Dec;2(6):495-6. doi: 10.1161/CIRCINTERVENTIONS.109.921577.
Abstract
摘要
相似文献
1
Clopidogrel for the hot patient.用于热证患者的氯吡格雷。
Circ Cardiovasc Interv. 2009 Dec;2(6):495-6. doi: 10.1161/CIRCINTERVENTIONS.109.921577.
2
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.经皮冠状动脉介入治疗后基线炎症标志物、抗血小板治疗与不良心脏事件的关系：来自氯吡格雷减少观察试验事件的分析。
Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17.
3
Stent thrombosis after drug eluting stent implantation.药物洗脱支架植入术后的支架内血栓形成。
Circ J. 2011;75(6):1316-7. doi: 10.1253/circj.cj-11-0407. Epub 2011 Apr 29.
4
Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein.经皮冠状动脉介入治疗前在阿司匹林基础上加用氯吡格雷对C反应蛋白相关风险的影响。
Am J Cardiol. 2001 Sep 15;88(6):672-4. doi: 10.1016/s0002-9149(01)01813-6.
5
Clopidogrel under scrutiny.
Catheter Cardiovasc Interv. 2008 Dec 1;72(7):925-6. doi: 10.1002/ccd.21871.
6
Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment.慢性氯吡格雷治疗患者的炎症生物标志物与血小板聚集之间的关系。
Thromb Haemost. 2010 Dec;104(6):1193-200. doi: 10.1160/TH10-05-0266. Epub 2010 Sep 13.
7
[Long-term therapy with clopidogrel in combination with ASA significantly reduces risk of death, myocardial infarct or stroke].
Minerva Med. 2003 Apr;94(2):XIII-IV.
8
Optimizing of thienopyridine therapy by multiple electrode platelet aggregometry in clopidogrel low responders undergoing PCI.经皮冠状动脉介入治疗中氯吡格雷低反应者应用多电极血小板聚集仪优化噻吩吡啶治疗。
Clin Res Cardiol. 2011 Oct;100(10):907-14. doi: 10.1007/s00392-011-0321-4. Epub 2011 Apr 30.
9
Coronary artery disease: Platelet activity: an obstacle for successful PCI.冠状动脉疾病：血小板活性：成功进行经皮冠状动脉介入治疗的一个障碍。
Nat Rev Cardiol. 2009 Jun;6(6):391-2. doi: 10.1038/nrcardio.2009.76.
10
Time dependence of clopidogrel loading effect: platelet activation versus platelet aggregation.氯吡格雷负荷效应的时间依赖性：血小板活化与血小板聚集
Thromb Res. 2012 Jan;129(1):1-2. doi: 10.1016/j.thromres.2011.07.048. Epub 2011 Aug 20.
引用本文的文献
1
Pregnancy morbidity in antiphospholipid syndrome: what is the impact of treatment?抗磷脂综合征中的妊娠并发症：治疗的影响有哪些？
Curr Rheumatol Rep. 2014 Feb;16(2):403. doi: 10.1007/s11926-013-0403-6.
本文引用的文献
1
Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.经皮冠状动脉介入治疗后基线炎症标志物、抗血小板治疗与不良心脏事件的关系：来自氯吡格雷减少观察试验事件的分析。
Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17.
2
The CD40/CD40 ligand system: linking inflammation with atherothrombosis.CD40/CD40配体系统：将炎症与动脉粥样硬化血栓形成相联系。
J Am Coll Cardiol. 2009 Aug 18;54(8):669-77. doi: 10.1016/j.jacc.2009.03.076.
3
Effect of clopidogrel with and without eptifibatide on tumor necrosis factor-alpha and C-reactive protein release after elective stenting: results from the CLEAR PLATELETS 1b study.
J Am Coll Cardiol. 2006 Dec 5;48(11):2186-91. doi: 10.1016/j.jacc.2005.12.084.
4
Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects.氯吡格雷可改善冠心病患者全身内皮一氧化氮生物利用度：抗氧化和抗炎作用的证据。
Arterioscler Thromb Vasc Biol. 2006 Jul;26(7):1648-52. doi: 10.1161/01.ATV.0000225288.74170.dc. Epub 2006 May 4.
5
Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting.氯吡格雷对接受冠状动脉支架置入术的不稳定型心绞痛患者循环中可溶性CD40配体水平抑制的影响。
Am J Cardiol. 2006 Jan 15;97(2):192-4. doi: 10.1016/j.amjcard.2005.08.023. Epub 2005 Nov 17.
6
GP IIb/IIIa inhibition with eptifibatide lowers levels of soluble CD40L and RANTES after percutaneous coronary intervention.使用依替巴肽抑制糖蛋白IIb/IIIa可降低经皮冠状动脉介入治疗后可溶性CD40配体和调节激活正常T细胞表达和分泌的趋化因子水平。
Catheter Cardiovasc Interv. 2004 Feb;61(2):185-9. doi: 10.1002/ccd.10763.
7
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study.阿司匹林单独使用或与氯吡格雷联合使用对急性冠状动脉综合征患者的影响：来自“氯吡格雷用于不稳定型心绞痛预防再发事件（CURE）”研究的观察结果
Circulation. 2003 Oct 7;108(14):1682-7. doi: 10.1161/01.CIR.0000091201.39590.CB. Epub 2003 Sep 22.
8
Inflammation in atherosclerosis.动脉粥样硬化中的炎症
Nature. 2002;420(6917):868-74. doi: 10.1038/nature01323.
9
Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.循环中的活化血小板会加剧载脂蛋白E缺乏小鼠的动脉粥样硬化。
Nat Med. 2003 Jan;9(1):61-7. doi: 10.1038/nm810. Epub 2002 Dec 16.
10
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).冠状动脉支架植入术后预防再狭窄的免疫抑制治疗（IMPRESS研究）
J Am Coll Cardiol. 2002 Dec 4;40(11):1935-42. doi: 10.1016/s0735-1097(02)02562-7.
Zotero 插件